BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23628694)

  • 1. An immunohistochemical study of the expression of the hypoxia markers Glut-1 and Ca-IX in canine sarcomas.
    Abbondati E; Del-Pozo J; Hoather TM; Constantino-Casas F; Dobson JM
    Vet Pathol; 2013 Nov; 50(6):1063-9. PubMed ID: 23628694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose transporter 1 expression in canine osteosarcoma.
    Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
    Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
    Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
    Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
    Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
    J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs.
    de Queiroz GF; Dagli ML; Fukumasu H; Zavala AA; Matera JM
    J Vet Diagn Invest; 2010 Jan; 22(1):105-8. PubMed ID: 20093695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous hypoxia markers: case not proven!
    Mayer A; Höckel M; Vaupel P
    Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia.
    Meier V; Guscetti F; Roos M; Ohlerth S; Pruschy M; Rohrer Bley C
    PLoS One; 2016; 11(2):e0149993. PubMed ID: 26906567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can sparsely and heterogeneously expressed proteins be detected using tissue microarrays? A simulation study of the hypoxia marker carbonic anhydrase IX (CA IX) in human soft tissue sarcoma.
    Måseide K; Pintilie M; Kandel R; Hill RP
    Pathol Res Pract; 2008; 204(3):175-83. PubMed ID: 18180112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
    Ahrens WA; Ridenour RV; Caron BL; Miller DV; Folpe AL
    Hum Pathol; 2008 Oct; 39(10):1519-26. PubMed ID: 18620729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
    Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL
    Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
    Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C
    Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the hypoxia-inducible factor pathway important in gastric cancer?
    Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
    Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
    Orrock JM; Abbott JJ; Gibson LE; Folpe AL
    Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
    Rafajová M; Zatovicová M; Kettmann R; Pastorek J; Pastoreková S
    Int J Oncol; 2004 Apr; 24(4):995-1004. PubMed ID: 15010840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
    Måseide K; Kandel RA; Bell RS; Catton CN; O'Sullivan B; Wunder JS; Pintilie M; Hedley D; Hill RP
    Clin Cancer Res; 2004 Jul; 10(13):4464-71. PubMed ID: 15240538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.